Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Joanna Tajer"'
Autor:
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska, Jan Walewski
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Primary mediastinal B-cell lymphoma (PMBL) is currently curable in 85–95% of patients. Treatment regimens frequently used include RCHOP ± radiotherapy, DAEPOCH-R, or occasionally more intensive protocols. Here we present results of treatm
Externí odkaz:
https://doaj.org/article/390d2e0cb00f467e8bbd36aeef3cedd8
Autor:
Beata Ostrowska, Katarzyna Domanska‐Czyz, Joanna Romejko‐Jarosinska, Michal Osowiecki, Lukasz Targonski, Lidia Poplawska, Robert Konecki, Martyna Kotarska, Marcin Szymanski, Anna Borawska, Monika Swierkowska, Anna Dabrowska‐Iwanicka, Agnieszka Druzd‐Sitek, Ewa Paszkiewicz‐Kozik, Ewa Mroz‐Zycinska, Joanna Tajer, Elzbieta Wojciechowska‐Lampka, Wlodzimierz Osiadacz, Grzegorz Rymkiewicz, Grazyna Lapinska, Marta Wojewodzka‐Mirocha, Wojciech Michalski, Jan Walewski
Publikováno v:
British Journal of Haematology. 201:663-672
Autor:
Michal Mikula, Agnieszka Paziewska, Filip Ambrozkiewicz, Jerzy Ostrowski, Aneta Balabas, Michalina Dąbrowska, Joanna Tajer, Martyna Kotarska, Lidia Poplawska, Ewa Paszkiewicz-Kozik, Jan Walewski, Maria Kulecka, Piotr Rutkowski, Jakub Karczmarski, Magdalena Piątkowska, Anna Kluska, Joanna Romejko-Jarosinska, Wlodzimierz Osiadacz, Natalia Żeber-Lubecka
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International, Vol 2021 (2021)
Hodgkin lymphoma (HL) and diffuse large B cell lymphoma (DLBCL) represent 15% and 20%, respectively, of all lymphoma types. The aim of this study was to identify and compare circulating serum miRNA (c-miRNA) and peripheral whole blood miRNA (wb-miRNA
Autor:
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska, Jan Walewski
Publikováno v:
Scientific reports. 12(1)
Primary mediastinal B-cell lymphoma (PMBL) is currently curable in 85–95% of patients. Treatment regimens frequently used include RCHOP ± radiotherapy, DAEPOCH-R, or occasionally more intensive protocols. Here we present results of treatment of 12
Autor:
Julien Viotti, Flavia Salvi, Waldemar Kulikowski, M.J. Ouvrier, Edyta Subocz, Simonetta Viviani, Maria Canepari, Andrea Gallamini, Maria Cantonetti, Marc Ettaiche, Silvia Bolis, Livio Trentin, Colette Zwarthoed, Luigi Rigacci, T.C. El-Galaly, Stefano Luminari, Bogdan Małkowski, Anna Borra, Jan Maciej Zaucha, Joanna Tajer, Chiara Rusconi, Jacques Darcourt
Publikováno v:
Zwarthoed, C, El-Galaly, T C, Canepari, M, Ouvrier, M J, Viotti, J, Ettaiche, M, Viviani, S, Rigacci, L, Trentin, L, Rusconi, C, Luminari, S, Cantonetti, M, Bolis, S, Borra, A, Darcourt, J, Salvi, F, Subocz, E, Tajer, J, Kulikowski, W, Malkowski, B, Zaucha, J M & Gallamini, A 2017, ' Prognostic value of bone marrow tracer uptake pattern in baseline PET scan in Hodgkin Lymphoma : results from an International Collaborative Study ', Journal of Nuclear Medicine, vol. 58, no. 8, pp. 1249-1254 . https://doi.org/10.2967/jnumed.116.184218
RATIONALE: Positron Emission Tomography/Computed Tomography (PET/CT)-ascertained bone marrow involvement (BMI) constitutes the single most important reason for upstaging by PET/CT in Hodgkin lymphoma (HL). However, BMI assessment in PET/CT can be cha
Autor:
W. Khair, Jan Maciej Zaucha, P. Juszczynski, J. Grad, Jan Walewski, M. Panebianco, Waldemar Kulikowski, Justyna Rybka, Ewa Chmielowska, T.C. El-Galaly, A. Romanowicz, Przemyslaw Biecek, R. Kroll-Balcerzak, Eldad J. Dann, Bogdan Małkowski, Giuseppe Cimino, Joanna Tajer, Andrea Gallamini, Edyta Subocz, Pawel Kurczab
Publikováno v:
Hematological Oncology. 35:313-315
Autor:
Agnieszka Druzd-Sitek, Anna Dabrowska-Iwanicka, Anna Borawska, Katarzyna Domanska-Czyz, Beata Ostrowska, Jan Walewski, Joanna Romejko-Jarosinska, Robert Konecki, Monika Swierkowska, Wlodzimierz Osiadacz, Elzbieta Wojciechowska-Lampka, Ewa Paszkiewicz-Kozik, Lukasz Targonski, Joanna Tajer, Lidia Poplawska, Martyna Kotarska, Marcin Szymanski
Publikováno v:
Journal of Clinical Oncology. 38:e20034-e20034
e20034 Background: Plasmablastic lymphoma (PBL) is a rare CD20-negative lymphoma with an aggressive clinical course and short median survival ranging from 9 to 32 months. It is often associated with HIV infection but it also affects immunocompetent p
Autor:
Federico Fallanca, A. Fijołek-Warszewska, M. Dziuk, Renata Zaucha, Krzysztof Leśniewski-Kmak, Dariusz Woszczyk, Dariusz Świetlik, Joanna Tajer, Waldemar Kulikowski, Wanda Knopinska-Posluszny, R. Kroll-Balcerzak, Tomasz Wróbel, Jan Walewski, Edyta Subocz, Jan Maciej Zaucha, Stephane Chauvie, Agnieszka Giza, A. Gallamini, Pawel Kurczab, Fabrizio Bergesio, Bogdan Małkowski, M. Kobylecka, A. Romanowicz, Alberto Biggi, A. Chamier-Ciemińska, Justyna Rybka
Background Interim PET after two ABVD cycles (iPET2) predicts treatment outcome in classical Hodgkin’s lymphoma. To test whether an earlier assessment of chemosensitivity would improve the prediction accuracy, we launched a prospective, multicenter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2672cf0469d2c7ef733c2eae0b59868
https://ruj.uj.edu.pl/xmlui/handle/item/141375
https://ruj.uj.edu.pl/xmlui/handle/item/141375
Autor:
Caterina Stelitano, Waldemar Kulikowski, Alessandra Romano, Lisa Argnani, Luigi Rigacci, Alessandro Levis, Fabio Fuligni, Pier Paolo Piccaluga, Anna Borra, Randy D. Gascoyne, Francesco d'Amore, Bogdan Małkowski, Claudio Agostinelli, Edyta Subocz, Stefano Pileri, Pier Luigi Zinzani, Livio Trentin, Luisa Stracqualursi, Maria Teresa Sista, Stephen Hamilton-Dutoit, Caterina Patti, Claudio Tripodo, Andrea Gallamini, Jan Maciej Zaucha, Alessandro Broccoli, Stefano Fanti, Francesco Merli, Alberto Biggi, Christian Steidl, Justyna Rybka, Umberto Vitolo, Joanna Tajer, Patrizia Agati, Peter Kamper
Publikováno v:
Agostinelli, C, Gallamini, A, Stracqualursi, L, Agati, P, Tripodo, C, Fuligni, F, Sista, M T, Fanti, S, Biggi, A, Vitolo, U, Rigacci, L, Merli, F, Patti, C, Romano, A, Levis, A, Trentin, L, Stelitano, C, Borra, A, Piccaluga, P P, Hamilton-Dutoit, S, Kamper, P, Zaucha, J M, Małkowski, B, Kulikowski, W, Tajer, J, Subocz, E, Rybka, J, Steidl, C, Broccoli, A, Argnani, L, Gascoyne, R D, d'Amore, F, Zinzani, P L & Pileri, S A 2016, ' The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma : a retrospective, European, multicentre cohort study ', The Lancet. Haematology, vol. 3, no. 10, pp. e467-e479 . https://doi.org/10.1016/S2352-3026(16)30108-9
BACKGROUND: Early-interim fluorodeoxyglucose (FDG)-PET scan after two ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy courses (PET-2) represents the most effective predictor of treatment outcome in classical Hodgkin's lymphom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e938ba130f6b8eebdc3e9dca76c61cbe
https://hdl.handle.net/20.500.11769/542314
https://hdl.handle.net/20.500.11769/542314
Autor:
Beata Kotowicz, Janina Kaminska, Magdalena Chechlinska, Jan Walewski, Joanna Tajer, Maria Kowalska, Malgorzata Fuksiewicz
Publikováno v:
Medical Oncology. 29:2143-2147
Macrophage colony-stimulating factor (M-CSF) was recently implicated by in vitro studies as a survival and proliferation factor for Hodgkin/Reed-Sternberg cells. We evaluated pre-treatment serum M-CSF levels in 66 patients with histopathologic diagno